Gene symbol: Kdr

Also known as: Vegfr-2

Organism: Rattus norvegicus

Summary: Enables growth factor binding activity and vascular endothelial growth factor-activated receptor activity. Involved in several processes, including generation of neurons; positive regulation of endothelial cell proliferation; and positive regulation of intracellular signal transduction. Located in several cellular components, including neuron projection; neuronal cell body; and plasma membrane. Used to study adhesions of uterus; brain ischemia; cystitis; and myocardial infarction. Biomarker of several diseases, including artery disease (multiple); impotence; ovarian hyperstimulation syndrome; prostate disease (multiple); and retinopathy of prematurity. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); gastrointestinal system cancer (multiple); glioblastoma; macular degeneration (multiple); and pancreatic cancer (multiple). Orthologous to human KDR (kinase insert domain receptor). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 25589 Ensembl:ENSRNOG00000046829 AllianceGenome:RGD:2965


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000165 MAPK cascade
Process GO:0000902 Cell morphogenesis
Process GO:0001501 Skeletal system development
Process GO:0001525 Angiogenesis
Process GO:0001541 Ovarian follicle development
Process GO:0001568 Blood vessel development
Process GO:0001569 Branching involved in blood vessel morphogenesis
Process GO:0001570 Vasculogenesis
Process GO:0001654 Eye development
Process GO:0001666 Response to hypoxia
Process GO:0001667 Ameboidal-type cell migration
Process GO:0001763 Morphogenesis of a branching structure
Process GO:0001894 Tissue homeostasis
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001936 Regulation of endothelial cell proliferation
Process GO:0001938 Positive regulation of endothelial cell proliferation
Process GO:0001944 Vasculature development
Process GO:0001945 Lymph vessel development
Process GO:0001952 Regulation of cell-matrix adhesion
Process GO:0001954 Positive regulation of cell-matrix adhesion
Process GO:0002009 Morphogenesis of an epithelium
Process GO:0002040 Sprouting angiogenesis
Process GO:0002042 Cell migration involved in sprouting angiogenesis
Process GO:0002053 Positive regulation of mesenchymal cell proliferation
Process GO:0002064 Epithelial cell development
Process GO:0002070 Epithelial cell maturation
Process GO:0002244 Hematopoietic progenitor cell differentiation
Process GO:0002376 Immune system process
Process GO:0002520 Immune system development
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003008 System process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0003073 Regulation of systemic arterial blood pressure
Process GO:0003085 Negative regulation of systemic arterial blood pressure
Process GO:0003157 Endocardium development
Process GO:0003158 Endothelium development
Process GO:0003159 Morphogenesis of an endothelium
Process GO:0003254 Regulation of membrane depolarization
Process GO:0003416 Endochondral bone growth
Process GO:0006468 Protein phosphorylation
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006950 Response to stress
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007167 Enzyme-linked receptor protein signaling pathway
Process GO:0007169 Transmembrane receptor protein tyrosine kinase signaling pathway
Process GO:0007204 Positive regulation of cytosolic calcium ion concentration
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007423 Sensory organ development
Process GO:0007507 Heart development
Process GO:0007548 Sex differentiation
Process GO:0007568 Aging
Process GO:0008015 Blood circulation
Process GO:0008152 Metabolic process
Process GO:0008217 Regulation of blood pressure
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008360 Regulation of cell shape
Process GO:0008406 Gonad development
Process GO:0008584 Male gonad development
Process GO:0008585 Female gonad development
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009611 Response to wounding
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009790 Embryo development
Process GO:0009791 Post-embryonic development
Process GO:0009886 Post-embryonic animal morphogenesis
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009894 Regulation of catabolic process
Process GO:0009896 Positive regulation of catabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010463 Mesenchymal cell proliferation
Process GO:0010464 Regulation of mesenchymal cell proliferation
Process GO:0010468 Regulation of gene expression
Process GO:0010506 Regulation of autophagy
Process GO:0010508 Positive regulation of autophagy
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010594 Regulation of endothelial cell migration
Process GO:0010595 Positive regulation of endothelial cell migration
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010629 Negative regulation of gene expression
Process GO:0010631 Epithelial cell migration
Process GO:0010632 Regulation of epithelial cell migration
Process GO:0010634 Positive regulation of epithelial cell migration
Process GO:0010638 Positive regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010720 Positive regulation of cell development
Process GO:0010810 Regulation of cell-substrate adhesion
Process GO:0010811 Positive regulation of cell-substrate adhesion
Process GO:0010821 Regulation of mitochondrion organization
Process GO:0010822 Positive regulation of mitochondrion organization
Process GO:0010941 Regulation of cell death
Process GO:0014066 Regulation of phosphatidylinositol 3-kinase signaling
Process GO:0014068 Positive regulation of phosphatidylinositol 3-kinase signaling
Process GO:0016043 Cellular component organization
Process GO:0016239 Positive regulation of macroautophagy
Process GO:0016241 Regulation of macroautophagy
Process GO:0016310 Phosphorylation
Process GO:0016477 Cell migration
Process GO:0018108 Peptidyl-tyrosine phosphorylation
Process GO:0018193 Peptidyl-amino acid modification
Process GO:0018212 Peptidyl-tyrosine modification
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0019722 Calcium-mediated signaling
Process GO:0019932 Second-messenger-mediated signaling
Process GO:0021700 Developmental maturation
Process GO:0022008 Neurogenesis
Process GO:0022414 Reproductive process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0022604 Regulation of cell morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030030 Cell projection organization
Process GO:0030097 Hemopoiesis
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030182 Neuron differentiation
Process GO:0030323 Respiratory tube development
Process GO:0030324 Lung development
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030510 Regulation of BMP signaling pathway
Process GO:0030513 Positive regulation of BMP signaling pathway
Process GO:0030855 Epithelial cell differentiation
Process GO:0031077 Post-embryonic camera-type eye development
Process GO:0031175 Neuron projection development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031329 Regulation of cellular catabolic process
Process GO:0031331 Positive regulation of cellular catabolic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0032006 Regulation of TOR signaling
Process GO:0032008 Positive regulation of TOR signaling
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032103 Positive regulation of response to external stimulus
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032989 Cellular component morphogenesis
Process GO:0032990 Cell part morphogenesis
Process GO:0033043 Regulation of organelle organization
Process GO:0033674 Positive regulation of kinase activity
Process GO:0035150 Regulation of tube size
Process GO:0035162 Embryonic hemopoiesis
Process GO:0035239 Tube morphogenesis
Process GO:0035265 Organ growth
Process GO:0035295 Tube development
Process GO:0035296 Regulation of tube diameter
Process GO:0035556 Intracellular signal transduction
Process GO:0035584 Calcium-mediated signaling using intracellular calcium source
Process GO:0035924 Cellular response to vascular endothelial growth factor stimulus
Process GO:0036211 Protein modification process
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036324 Vascular endothelial growth factor receptor-2 signaling pathway
Process GO:0038033 Positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway
Process GO:0038083 Peptidyl-tyrosine autophosphorylation
Process GO:0038084 Vascular endothelial growth factor signaling pathway
Process GO:0038089 Positive regulation of cell migration by vascular endothelial growth factor signaling pathway
Process GO:0040007 Growth
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042060 Wound healing
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042311 Vasodilation
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042391 Regulation of membrane potential
Process GO:0042592 Homeostatic process
Process GO:0042981 Regulation of apoptotic process
Process GO:0043010 Camera-type eye development
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043129 Surfactant homeostasis
Process GO:0043170 Macromolecule metabolic process
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043412 Macromolecule modification
Process GO:0043491 Protein kinase B signaling
Process GO:0043523 Regulation of neuron apoptotic process
Process GO:0043524 Negative regulation of neuron apoptotic process
Process GO:0043534 Blood vessel endothelial cell migration
Process GO:0043535 Regulation of blood vessel endothelial cell migration
Process GO:0043536 Positive regulation of blood vessel endothelial cell migration
Process GO:0043542 Endothelial cell migration
Process GO:0043549 Regulation of kinase activity
Process GO:0044087 Regulation of cellular component biogenesis
Process GO:0044089 Positive regulation of cellular component biogenesis
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0045137 Development of primary sexual characteristics
Process GO:0045165 Cell fate commitment
Process GO:0045446 Endothelial cell differentiation
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045765 Regulation of angiogenesis
Process GO:0045766 Positive regulation of angiogenesis
Process GO:0045776 Negative regulation of blood pressure
Process GO:0045785 Positive regulation of cell adhesion
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0046545 Development of primary female sexual characteristics
Process GO:0046546 Development of primary male sexual characteristics
Process GO:0046660 Female sex differentiation
Process GO:0046661 Male sex differentiation
Process GO:0046777 Protein autophosphorylation
Process GO:0048010 Vascular endothelial growth factor receptor signaling pathway
Process GO:0048050 Post-embryonic eye morphogenesis
Process GO:0048167 Regulation of synaptic plasticity
Process GO:0048168 Regulation of neuronal synaptic plasticity
Process GO:0048169 Regulation of long-term neuronal synaptic plasticity
Process GO:0048170 Positive regulation of long-term neuronal synaptic plasticity
Process GO:0048286 Lung alveolus development
Process GO:0048468 Cell development
Process GO:0048469 Cell maturation
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048534 Hematopoietic or lymphoid organ development
Process GO:0048563 Post-embryonic animal organ morphogenesis
Process GO:0048568 Embryonic organ development
Process GO:0048569 Post-embryonic animal organ development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048589 Developmental growth
Process GO:0048592 Eye morphogenesis
Process GO:0048593 Camera-type eye morphogenesis
Process GO:0048597 Post-embryonic camera-type eye morphogenesis
Process GO:0048608 Reproductive structure development
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048666 Neuron development
Process GO:0048699 Generation of neurons
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048754 Branching morphogenesis of an epithelial tube
Process GO:0048812 Neuron projection morphogenesis
Process GO:0048856 Anatomical structure development
Process GO:0048858 Cell projection morphogenesis
Process GO:0048869 Cellular developmental process
Process GO:0048870 Cell motility
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048875 Chemical homeostasis within a tissue
Process GO:0048878 Chemical homeostasis
Process GO:0048880 Sensory system development
Process GO:0050673 Epithelial cell proliferation
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050679 Positive regulation of epithelial cell proliferation
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050801 Ion homeostasis
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050848 Regulation of calcium-mediated signaling
Process GO:0050850 Positive regulation of calcium-mediated signaling
Process GO:0050896 Response to stimulus
Process GO:0050920 Regulation of chemotaxis
Process GO:0050921 Positive regulation of chemotaxis
Process GO:0050926 Regulation of positive chemotaxis
Process GO:0050927 Positive regulation of positive chemotaxis
Process GO:0051094 Positive regulation of developmental process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051716 Cellular response to stimulus
Process GO:0051769 Regulation of nitric-oxide synthase biosynthetic process
Process GO:0051770 Positive regulation of nitric-oxide synthase biosynthetic process
Process GO:0051881 Regulation of mitochondrial membrane potential
Process GO:0051893 Regulation of focal adhesion assembly
Process GO:0051894 Positive regulation of focal adhesion assembly
Process GO:0051900 Regulation of mitochondrial depolarization
Process GO:0051901 Positive regulation of mitochondrial depolarization
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0055065 Metal ion homeostasis
Process GO:0055074 Calcium ion homeostasis
Process GO:0055080 Cation homeostasis
Process GO:0060055 Angiogenesis involved in wound healing
Process GO:0060249 Anatomical structure homeostasis
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060284 Regulation of cell development
Process GO:0060348 Bone development
Process GO:0060429 Epithelium development
Process GO:0060541 Respiratory system development
Process GO:0060548 Negative regulation of cell death
Process GO:0060562 Epithelial tube morphogenesis
Process GO:0060837 Blood vessel endothelial cell differentiation
Process GO:0061042 Vascular wound healing
Process GO:0061138 Morphogenesis of a branching epithelium
Process GO:0061154 Endothelial tube morphogenesis
Process GO:0061458 Reproductive system development
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070371 ERK1 and ERK2 cascade
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070374 Positive regulation of ERK1 and ERK2 cascade
Process GO:0070482 Response to oxygen levels
Process GO:0070848 Response to growth factor
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071363 Cellular response to growth factor stimulus
Process GO:0071526 Semaphorin-plexin signaling pathway
Process GO:0071695 Anatomical structure maturation
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072089 Stem cell proliferation
Process GO:0072091 Regulation of stem cell proliferation
Process GO:0072359 Circulatory system development
Process GO:0072507 Divalent inorganic cation homeostasis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090049 Regulation of cell migration involved in sprouting angiogenesis
Process GO:0090050 Positive regulation of cell migration involved in sprouting angiogenesis
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090092 Regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090100 Positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090109 Regulation of cell-substrate junction assembly
Process GO:0090130 Tissue migration
Process GO:0090132 Epithelium migration
Process GO:0090140 Regulation of mitochondrial fission
Process GO:0090141 Positive regulation of mitochondrial fission
Process GO:0090287 Regulation of cellular response to growth factor stimulus
Process GO:0090596 Sensory organ morphogenesis
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0098771 Inorganic ion homeostasis
Process GO:0098868 Bone growth
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0120039 Plasma membrane bounded cell projection morphogenesis
Process GO:0150063 Visual system development
Process GO:0150116 Regulation of cell-substrate junction organization
Process GO:0150117 Positive regulation of cell-substrate junction organization
Process GO:1901214 Regulation of neuron death
Process GO:1901215 Negative regulation of neuron death
Process GO:1901342 Regulation of vasculature development
Process GO:1901532 Regulation of hematopoietic progenitor cell differentiation
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901888 Regulation of cell junction assembly
Process GO:1901890 Positive regulation of cell junction assembly
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1903010 Regulation of bone development
Process GO:1904018 Positive regulation of vasculature development
Process GO:1904035 Regulation of epithelial cell apoptotic process
Process GO:1904036 Negative regulation of epithelial cell apoptotic process
Process GO:1904181 Positive regulation of membrane depolarization
Process GO:1904880 Response to hydrogen sulfide
Process GO:1904881 Cellular response to hydrogen sulfide
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000351 Regulation of endothelial cell apoptotic process
Process GO:2000352 Negative regulation of endothelial cell apoptotic process
Process GO:2000648 Positive regulation of stem cell proliferation
Process GO:2001026 Regulation of endothelial cell chemotaxis
Process GO:2001028 Positive regulation of endothelial cell chemotaxis
Process GO:2001212 Regulation of vasculogenesis
Process GO:2001214 Positive regulation of vasculogenesis
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005768 Endosome
Component GO:0005769 Early endosome
Component GO:0005783 Endoplasmic reticulum
Component GO:0005794 Golgi apparatus
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0009897 External side of plasma membrane
Component GO:0009986 Cell surface
Component GO:0012505 Endomembrane system
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0030054 Cell junction
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0031410 Cytoplasmic vesicle
Component GO:0031982 Vesicle
Component GO:0032991 Protein-containing complex
Component GO:0036477 Somatodendritic compartment
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043235 Receptor complex
Component GO:0044297 Cell body
Component GO:0045121 Membrane raft
Component GO:0070161 Anchoring junction
Component GO:0071944 Cell periphery
Component GO:0097443 Sorting endosome
Component GO:0097708 Intracellular vesicle
Component GO:0098552 Side of membrane
Component GO:0098857 Membrane microdomain
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Function GO:0000166 Nucleotide binding
Function GO:0003824 Catalytic activity
Function GO:0004672 Protein kinase activity
Function GO:0004713 Protein tyrosine kinase activity
Function GO:0004714 Transmembrane receptor protein tyrosine kinase activity
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0005021 Vascular endothelial growth factor receptor activity
Function GO:0005102 Signaling receptor binding
Function GO:0005178 Integrin binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005524 ATP binding
Function GO:0015026 Coreceptor activity
Function GO:0016301 Kinase activity
Function GO:0016740 Transferase activity
Function GO:0016772 Transferase activity, transferring phosphorus-containing groups
Function GO:0016773 Phosphotransferase activity, alcohol group as acceptor
Function GO:0017076 Purine nucleotide binding
Function GO:0019199 Transmembrane receptor protein kinase activity
Function GO:0019838 Growth factor binding
Function GO:0030554 Adenyl nucleotide binding
Function GO:0032553 Ribonucleotide binding
Function GO:0032555 Purine ribonucleotide binding
Function GO:0032559 Adenyl ribonucleotide binding
Function GO:0035639 Purine ribonucleoside triphosphate binding
Function GO:0036094 Small molecule binding
Function GO:0038023 Signaling receptor activity
Function GO:0038085 Vascular endothelial growth factor binding
Function GO:0042802 Identical protein binding
Function GO:0043167 Ion binding
Function GO:0043168 Anion binding
Function GO:0044877 Protein-containing complex binding
Function GO:0045296 Cadherin binding
Function GO:0050839 Cell adhesion molecule binding
Function GO:0060089 Molecular transducer activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:0140096 Catalytic activity, acting on a protein
Function GO:1901265 Nucleoside phosphate binding
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-162582 Signal Transduction
RCTM RNO-194138 Signaling by VEGF
RCTM RNO-194306 Neurophilin interactions with VEGF and VEGFR
RCTM RNO-194313 VEGF ligand-receptor interactions
RCTM RNO-195399 VEGF binds to VEGFR leading to receptor dimerization
RCTM RNO-4420097 VEGFA-VEGFR2 Pathway
RCTM RNO-5218921 VEGFR2 mediated cell proliferation
RCTM RNO-9006934 Signaling by Receptor Tyrosine Kinases
WikiPathways WP188 Focal adhesion
WikiPathways WP397 ID signaling pathway
KEGG rno01521 EGFR tyrosine kinase inhibitor resistance
KEGG rno04010 MAPK signaling pathway
KEGG rno04014 Ras signaling pathway
KEGG rno04015 Rap1 signaling pathway
KEGG rno04020 Calcium signaling pathway
KEGG rno04151 PI3K-Akt signaling pathway
KEGG rno04370 VEGF signaling pathway
KEGG rno04510 Focal adhesion
KEGG rno05205 Proteoglycans in cancer
KEGG rno05418 Fluid shear stress and atherosclerosis

Expression profile of Kdr in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 14.915339
GSM2685202 MX2 tissue: Myocardium gender: female 14.705147
GSM2685203 MX3 tissue: Myocardium gender: female 15.280097
GSM2685204 MX4 tissue: Myocardium gender: male 14.9793415
GSM2685205 DZ1 tissue: Myocardium gender: male 14.846647
GSM2685206 DZ2 tissue: Myocardium gender: male 14.913448
GSM2685207 DZ3 tissue: Myocardium gender: female 14.846647
GSM2685208 DZ4 tissue: Myocardium gender: female 14.837589
GSM2685209 JJ1 tissue: Myocardium gender: male 14.629045
GSM2685210 JJ2 tissue: Myocardium gender: female 14.660591
GSM2685211 JJ3 tissue: Myocardium gender: female 14.87468
GSM2685212 JJ4 tissue: Myocardium gender: male 14.931069
GSM2685213 NG1 tissue: Myocardium gender: male 14.548352
GSM2685214 NG2 tissue: Myocardium gender: female 14.793235
GSM2685215 NG3 tissue: Myocardium gender: male 14.798666
GSM2685216 NG4 tissue: Myocardium gender: female 14.860038
GSM2685217 YL1 tissue: Myocardium gender: male 14.390603
GSM2685218 YL2 tissue: Myocardium gender: male 14.906533
GSM2685219 YL3 tissue: Myocardium gender: female 14.784433
GSM2685220 YL4 tissue: Myocardium gender: female 14.890596
GSM2685221 QC1 tissue: Myocardium gender: male 14.582178
GSM2685222 QC2 tissue: Myocardium gender: male 14.542521
GSM2685223 QC3 tissue: Myocardium gender: female 14.532643
GSM2685224 QC4 tissue: Myocardium gender: female 14.65477

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.49496229
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.981981505
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.933941636
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.53508367
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.171519111
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.798517308

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 119.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 78.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 127.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 89.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 453.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 475.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 705.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1253.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 258.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 200.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 269.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 416.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 546.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1050.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 884.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 876.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.470386
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.5529
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.584152
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.799836
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.036757
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.028721

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 3.45
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 3.23
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 4.788
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 3.159
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 3.651

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 6.919116805
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 6.4568618635
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 5.7975110700000005

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 84.3
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 226.2
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 165.1
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 49.2
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 177.2
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 97.8
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 241.1
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 141.5
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 210.6
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 116.4
GSM27494 CTL_a (control, 1st replicate) 53.6
GSM27495 CTL_b (control, 2nd replicate) 69.2
GSM27496 CTL_c (control, 3rd replicate) 248.0
GSM27497 CTL_d (control, 4th replicate) 114.9
GSM27498 CTL_e (control, 5th replicate) 185.5
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 220.2
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 112.3
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 152.0
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 172.1
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 203.0
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 314.2
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 290.8
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 106.2
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 247.6
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 216.6
GSM27509 ISCH_a (ischemia, 1st replicate) 323.4
GSM27510 ISCH_b (ischemia, 2nd replicate) 251.2
GSM27511 ISCH_c (ischemia, 3rd replicate) 137.4
GSM27512 ISCH_d (ischemia, 4th replicate) 371.7
GSM27513 ISCH_e (ischemia, 5th replicate) 113.3

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 121.8
GSM30791 baseline control 02 male, 275-300g 82.9
GSM30792 baseline control 03 male, 275-300g 76.5
GSM30793 baseline control 04 male, 275-300g 73.7
GSM30794 baseline control 05 male, 275-300g 73.5
GSM30795 baseline control 06 male, 275-300g 112.6
GSM30796 baseline control 07 male, 275-300g 94.3
GSM30797 baseline control 08 male, 275-300g 80.3
GSM30798 baseline control 09 male, 275-300g 53.5
GSM30799 pain 01 89.4
GSM30800 pain 02 96.8
GSM30801 pain 03 105.4
GSM30802 pain 04 111.3
GSM30803 pain 05 64.9
GSM30804 FC 01 125.8
GSM30805 FC 02 122.8
GSM30806 FC 03 97.5
GSM30807 FC 04 69.1
GSM30808 FC 05 112.3
GSM30809 IFC 01 121.7
GSM30810 IFC 02 110.2
GSM30811 IFC 03 136.0
GSM30812 IFC 04 81.8
GSM30813 IFC 05 91.6
GSM99800 isoflurane 01 male, 275-300g 71.9
GSM99801 isoflurane 02 male, 275-300g 62.1
GSM99802 isoflurane 03 male, 275-300g 68.8
GSM99803 isoflurane 04 male, 275-300g 74.2
GSM99804 isoflurane 05 male, 275-300g 101.2

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 64.8967
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 86.014
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 67.10025
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 71.304
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 31.7397
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 57.702999999999996
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 52.1782
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 46.834700000000005
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 97.8264

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 7.14542
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 7.23703
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 5.43409
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 6.26725
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 7.08598
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 6.37833
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 8.28025
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 7.58218
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 6.59414
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 6.87398
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 5.59476
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 6.08626
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 6.12522
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 5.97025
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 6.54564
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 6.4537

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.161129
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.096227
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.192742
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.110254
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 10.902199
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.689576
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.509492
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.722613
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.712811
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 10.655179
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.75918
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.655179
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.692911
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.655179
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 10.7016
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.64654
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.857391
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.658071
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.714323
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 10.673072
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 11.157132
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.672258
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.783232
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.435847
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 10.607118
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.821246
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.602343
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.656581
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.683325
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.811279
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.841427
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.440475
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.441086
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.593624
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.510613
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 9.477266
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.33664
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.48755
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 9.956803
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 9.643788
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 10.332829
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 10.555321
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 10.675421
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 10.446413
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 10.436647

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 93.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 73.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 98.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 108.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 95.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 94.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 104.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 97.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 82.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 153.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 68.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 151.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 152.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 125.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 141.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 99.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 77.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 68.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 109.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 77.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 103.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 117.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 99.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 77.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 108.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 84.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 67.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 112.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 110.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 124.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 134.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 115.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 145.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 83.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 110.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 75.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 52.718105
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 47.640602
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 50.206333
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 54.03178

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.00223
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0573
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.0971
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.0517
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.0289
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0326
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.0888
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.0126
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0942
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.0995
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.1
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.0903

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 37.0
GSM5121 Isoflurane single exposure control-2 26.5
GSM5122 Isoflurane single exposure control-3 5.4
GSM5124 Isoflurane single exposure 1 hr-1 44.2
GSM5126 Isoflurane single exposure 1 hr-2 20.5
GSM5127 Isoflurane single exposure 2 hr-1 21.2
GSM5130 Isoflurane single exposure 2 hr-2 17.7
GSM5131 Isoflurane single exposure 2 hr-3 33.4

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.1949756535
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.2582857635
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.64311909
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.5750151685
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.824911843
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.058036769999999
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.725088093
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.6791227735
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.6124571735
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.8898029675
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.633901329
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.028070018999999
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.9694575405000005
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.843230420499999
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.035070713
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.307374734
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.5444402355
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.5391211694999996
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.0211151495
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.8900526345
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.898529301
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.933061914
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.8140999915
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.6771162275

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 71.9178263105
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 214.72778801200002
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 209.64903239
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 83.4485404
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 65.7908871625
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 105.93424208
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 81.5668212245
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 114.028256058
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 96.60822239000001
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 171.19043957999997
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 220.00530370450002
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 135.63607002499998
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 153.581020595
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 130.333394829

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.1949756535
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.2582857635
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.64311909
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.5750151685
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.824911843
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.058036769999999
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.725088093
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.6791227735
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.6124571735
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.8898029675
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.633901329
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.028070018999999
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.9694575405000005
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.843230420499999
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.035070713
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.307374734
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 6.5444402355
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.5391211694999996
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.0211151495
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.8900526345
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.898529301
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.933061914
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.8140999915
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.6771162275
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 71.9178263105
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 214.72778801200002
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 209.64903239
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 83.4485404
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 65.7908871625
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 105.93424208
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 81.5668212245
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 114.028256058
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 96.60822239000001
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 171.19043957999997
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 220.00530370450002
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 135.63607002499998
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 153.581020595
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 130.333394829

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 32.5
GSM5084 Control 2 27.7
GSM5085 Control 3 19.9
GSM5086 Control 4 26.1
GSM5087 Control 5 39.7
GSM5090 Control 6 45.0
GSM5105 Control 7 42.5
GSM5106 Control 8 31.7
GSM5107 Control 9 31.8
GSM5108 Halothane 10 exposure-1 22.9
GSM5109 Halothane 10 exposures-2 31.6
GSM5110 Halothane 10 exposures-3 31.2
GSM5111 Halothane 5 exposures-1 39.5
GSM5112 Halothane 5 exposures-2 36.5
GSM5113 Halothane 5 exposures-3 27.9
GSM5114 Isoflurane 10 exposures-1 30.4
GSM5115 Isoflurane 10 exposures-2 56.2
GSM5116 Isoflurane 10 exposures-3 17.5
GSM5117 Isoflurane 5 exposures-1 20.0
GSM5118 Isoflurane 5 exposures-2 33.3
GSM5119 Isoflurane 5 exposures-3 24.5
GSM11379 Control 10 68.0
GSM11380 Control 11 33.7
GSM11381 Control 12 24.6

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 26.89828
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 52.728045